Growing at a rapid pace, the Indian healthcare industry is expected to become a US$280 billion industry by 2020. It is all set to emerge as one of the top 5 global markets for pharmaceutical products.
Factors driving this growth are rising income levels and growing elderly population. In addition, changing demographics, disease profiles and the shift from chronic to lifestyle diseases in the country has led to increased spending on healthcare. About 650 million people will have health insurance cover by 2020 with the private insurance coverage growing annually by 15%.
Micro Labs, Sun Pharma, Cipla & Glenmark, the top 4 major pharmaceutical companies in India have been nominated by Indian Affairs Business Leadership Awards 2012.
'Indian Affairs' magazine in partnership with 'Analytical & Interactive Pharmaleader's magazine have been asked to do a market survey of doctors to choose their best partner while treating patients & administering the drugs on them.
All the 4 leading national players will be tested & diagnosed by the doctors who will choose the coveted "India's Most Valuable Pharmaceutical Company 2012". On April 6th 2012, the winner will be announced at the 3rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2012 in Bengaluru.